Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody

References

• Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–7. doi: 10.1016/S0140-6736(22)00478-0.
   PubMed Web of Science ®Google Scholar
• Halasa N, Zambrano LD, Amarin JZ, Stewart LS, Newhams MM, Levy ER, Shein SL, Carroll CL, Fitzgerald JC, Michaels MG, et al. Infants admitted to us intensive care units for RSV infection during the 2022 seasonal peak. JAMA Netw Open. 2023;6(8):2328950–50. doi: 10.1001/jamanetworkopen.2023.28950.
   Web of Science ®Google Scholar
• Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98. doi: 10.1056/NEJMoa0804877.
   PubMed Web of Science ®Google Scholar
• Kilich E, Dada S, Francis MR, Tazare J, Chico RM, Paterson P, Larson HJ. Factors that influence vaccination decision-making among pregnant women: a systematic review and meta-analysis. PLoS One. 2020;15(7):e0234827. doi: 10.1371/journal.pone.0234827.
   PubMed Web of Science ®Google Scholar
• Baïssas T, Boisnard F, Cuesta Esteve I, Garcia Sánchez M, Jones CE, Rigoine de Fougerolles T, Tan L, Vitoux O, Klein C. Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain. BMC Public Health. 2021;21(1):2182. doi: 10.1186/s12889-021-12198-2.
   PubMed Web of Science ®Google Scholar
• Agency UHS. Pertussis vaccination coverage for pregnant women in England, January to March and annual coverage 2021 to 2022. 2023 [accessed 2023 Aug 17]. https://www.gov.uk/government/publications/pertussis-immunisation-in-pregnancy-vaccine-coverage-estimates-in-england-october-2013-to-march-2014/pertussis-vaccination-coverage-for-pregnant-women-in-england-january-to-march-and-annual-coverage-2021-to-2022.
   Google Scholar
• National Health Service. Childhood vaccination coverage statistics. 2023. https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/2021-22.
   Google Scholar
• Control CfDPa. Flu, Tdap, and COVID-19 vaccination coverage among pregnant women – United States. 2022 Apr [accessed 2023 Aug 10]. https://www.cdc.gov/flu/fluvaxview/pregnant-women-apr2022.htm.
   Google Scholar
• Centers for Disease Prevention and Control. Vaccination coverage among young children (0 – 35 months). Child vax view. 2023 [accessed 2023 Aug 17]. https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/interactive-reports/index.html.
   Google Scholar
• Quattrocchi A, Mereckiene J, Fitzgerald M, Cotter S. Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: a cross-sectional survey in 2017/18 influenza season. Vaccine. 2019;37(43):6390–6. doi: 10.1016/j.vaccine.2019.09.008.
   PubMed Web of Science ®Google Scholar
• Health Protection Surveillance Centre. Annual epidemiological report, immunisation uptake at 12 and 24 months of age, 2018. Oct 2019.
   Google Scholar
• Moir D, Gunter K, Lynch L-A, Vogrin S, Said J. Antenatal vaccine uptake: a cross-sectional study investigating factors influencing women’s choices in pregnancy. Aust N Z J Obstet Gynaecol. 2020;60(5):729–37. doi: 10.1111/ajo.13146.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health and Aged Care. Historical coverage data tables for all children 2023. [accessed 2023 Aug 20]. https://www.health.gov.au/topics/immunisation/immunisation-data/childhood-immunisation-coverage/historical-coverage-data-tables-for-all-children.
   Google Scholar
• World Health Organization. Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage 2023. [accessed 2023 Sep 6]. https://immunizationdata.who.int/pages/coverage/dtp.html.
   Google Scholar
• Vilca LM, Cesari E, Tura AM, Di Stefano A, Vidiri A, Cavaliere AF, Cetin I. Barriers and facilitators regarding influenza and pertussis maternal vaccination uptake: a multi-center survey of pregnant women in Italy. Eur J Obstet Gyn R B. 2020;247:10–15. doi: 10.1016/j.ejogrb.2020.02.007.
   PubMed Web of Science ®Google Scholar
• De Sanidad M. Statistical portal, management intelligence area 2022. https://pestadistico.inteligenciadegestion.sanidad.gob.es/publicoSNS/I/sivamin/informe-de-evolucion-de-coberturas-de-vacunacion-por-vacuna.
   Google Scholar
• Liptakova M, Kostalova J, Kyncl J, Maly M, Krizova M, Herman H, Fabianova K. Monitoring the vaccination of pregnant women against pertussis – single-centre one-year study in the Czech Republic. Bratisl Lek Listy. 2023;124(4):285–91. doi: 10.4149/bll_2023_044.
   PubMed Web of Science ®Google Scholar
• Li W-F, Huang S-Y, Peng H-H, Chang Y-L, Chang S-D, Cheng P-J, Hsiao C-H, Su Y-N, Lin T-H, Cheng C-C, et al. Factors affecting pregnant women’s decisions regarding prenatal pertussis vaccination: a decision-making study in the nationwide prenatal pertussis immunization program in Taiwan. Taiwan J Obstet Gynecol. 2020;59(2):200–6. doi: 10.1016/j.tjog.2020.01.006.
   PubMed Web of Science ®Google Scholar
• Taiwan Centers for Disease Control. Immunisation coverage annual data 2018. 2018 [accessed 2023 Sep 6]. https://www.cdc.gov.tw/En/File/Get?q=66HT6AZdVjKmPmyJ9OclbN7CNOQutN9PFFxeN2TdMISKPtMWSgSzDVDybg45vRlAAttIgkIvcEux6tt4VtlVGbkjthS6fSjqyavkCQSxN758LF0RJbQ-X9pTNKXzC4lfNNxGaaOUErNEo5zLnTa6Z_YepH8lWj5Ous24XvzjRKk.
   Google Scholar
• World Health Organization (WHO). COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades 2022. [accessed 2014 Mar 20]. https://www.who.int/news/item/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades.
   Google Scholar
• Cotter SB, Taylor LL, Grace R, Miao D, Coleman MA, Ratan BM. Effects of the COVID-19 pandemic on routine maternal vaccine uptake [A176]. Obstet Gynecol. 2022;139(1):51S–51S. doi: 10.1097/01.AOG.0000825980.61496.81.
   Google Scholar
• MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4. doi: 10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33(47):6420–9. doi: 10.1016/j.vaccine.2015.08.046.
   PubMed Web of Science ®Google Scholar
• Giles ML, Buttery J, Davey M-A, Wallace E. Pregnant women’s knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines. Vaccine. 2019;37(44):6743–9. doi: 10.1016/j.vaccine.2019.08.084.
   PubMed Web of Science ®Google Scholar
• McCormack S, Thompson C, Cahthasaigh CN, Nolan M, Imcha M, Dee A, Saunders J, Philip RK. Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy. Arch Dis Child. 2019;104:A135.
   Web of Science ®Google Scholar
• Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, Heath PT, Khalil A, Finn A, Snape MD, et al. Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: a multicenter questionnaire study. Pediatr Infect Dis J. 2019;38(9):944–51. doi: 10.1097/inf.0000000000002384.
   PubMed Web of Science ®Google Scholar
• Geoghegan S, Shuster S, Butler KM, Feemster KA. Understanding barriers and facilitators to maternal immunization: a systematic narrative synthesis of the published literature. Matern Child Health J. 2022;26(11):2198–209. doi: 10.1007/s10995-022-03508-0.
   PubMed Web of Science ®Google Scholar
• Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, et al. Bivalent prefusion f vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023;388(16):1451–64. doi: 10.1056/NEJMoa2216480.
   PubMed Web of Science ®Google Scholar
• Pfizer. A trial to evaluate the efficacy and safety of rsvpref in infants born to women vaccinated during pregnancy NCT04424316 2024 [accessed 2024 Mar 20]. https://clinicaltrials.gov/study/NCT04424316?intr=RSVpreF&rank=3.
   Google Scholar
• Dieussaert I, Hyung Kim J, Luik S, Seidl C, Pu W, Stegmann J-U, Swamy GK, Webster P, Dormitzer PR. RSV prefusion f protein–based maternal vaccine — preterm birth and other outcomes. N Engl J Med. 2024;390(11):1009–21. doi: 10.1056/NEJMoa2305478.
   PubMedGoogle Scholar
• Fleming-Dutra K. Evidence to recommendations framework: pfizer maternal RSVpreF vaccine. ACIP meeting presentation. 2023 Jun 22 [accessed 2023 Aug 25]. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-06-21-23/03-RSV-Mat-Ped-Fleming-Dutra-508.pdf.
   Google Scholar
• Domachowske J, Madhi SA, Simões EAF, Atanasova V, CabañCabañAs F, Furuno K, Garcia-Garcia ML, Grantina I, Nguyen KA, Brooks D, et al. Safety of Nirsevimab for RSV in infants with heart or lung disease or prematurity. N Engl J Med. 2022;386(9):892–4. doi: 10.1056/NEJMc2112186.
   PubMed Web of Science ®Google Scholar
• Drysdale S, Cathie K, Flamein F, Knuf M, Collins A, Hill H. Efficacy of nirsevimab against RSV lower respiratory tract infection hospitalization in infants: preliminary data from the HARMONIE phase 3b trial. Presented at 41st annual meeting of the European society for paediatric infectious diseases in Lisbon; 2023
   Google Scholar
• Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, Simões EAF, Esser MT, Khan AA, Dubovsky F, et al. Single-dose nirsevimab for prevention of RSV in preterm infants. N Engl J Med. 2020;383(5):415–25. doi: 10.1056/NEJMoa1913556.
   PubMed Web of Science ®Google Scholar
• Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC, Kaiser F, Cohen R, Pinquier D, Felter CT, et al. Nirsevimab for prevention of hospitalizations due to RSV in infants. N Engl J Med. 2023;389(26):2425–35. doi: 10.1056/NEJMoa2309189.
   PubMed Web of Science ®Google Scholar
• Qiu X, Bailey H, Thorne C. Barriers and facilitators associated with vaccine acceptance and uptake among pregnant women in high income countries: a mini-review. Front Immunol. 2021;12. doi: 10.3389/fimmu.2021.626717.
   Web of Science ®Google Scholar
• Geoghegan S, Acosta F, Stephens LC, Gillan H, Valera S, Drew RJ, Eogan M, Ratner AJ, Steenhoff AP, Butler KM, et al. Maternity care provider acceptance of a future group B Streptococcus vaccine – a qualitative study in three countries. Vaccine. 2023;41(12):2013–21. doi: 10.1016/j.vaccine.2023.02.037.
   PubMed Web of Science ®Google Scholar
• O’Leary ST, Yonts AB, Gaviria-Agudelo C, Kimberlin DW. Paulsen GC SummerACIP update: RSV prevention and updated recommendations on other vaccines Pediatrics. 2023; 1525. doi: 10.1542/peds.2023-063955.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Healthcare providers: RSV vaccination for pregnant people 2023 [accessed 2023 Nov 10]. https://www.cdc.gov/vaccines/vpd/rsv/hcp/pregnant-people.html.
   Google Scholar
• Centre for Disease Control and Prevention. Healthcare providers: RSV prevention information. RSV immunization for infants and young children. 2023 [accessed 2023 Oct 2]. https://www.cdc.gov/vaccines/vpd/rsv/hcp/child.html.
   Google Scholar
• Lee Mortensen G, Harrod-Lui K. Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies. Expert Rev Vaccines. 2022;21(10):1523–31. doi: 10.1080/14760584.2022.2108799.
   PubMed Web of Science ®Google Scholar
• Dugovich AM, Cox TH, Weeda ER, Garner SS. First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic. Vaccine. 2023;41(17):2824–8. published Online First: 20230327. doi: 10.1016/j.vaccine.2023.03.039.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Bacillus Calmette–Guérin (BCG) vaccination coverage 2023. [accessed 2023 Nov 20]. https://immunizationdata.who.int/pages/coverage/bcg.html?CODE=PAK&YEAR=.
   Google Scholar
• Loyal J, Shapiro ED. Refusal of intramuscular vitamin K by parents of newborns: a review. Hosp Pediatr. 2020;10(3):286–94. published Online First: 20200204. doi: 10.1542/hpeds.2019-0228.
   PubMedGoogle Scholar
• Haute Autorite de Sante (France). Nirsévimab (Beyfortus ®) dans la prévention des bronchiolites à virus respiratoire syncytial (VRS) chez les nouveau-nés et les nourrissons. 2023 Sept 14. https://www.has-sante.fr/jcms/p_3461236/fr/nirsevimab-beyfortus-dans-la-prevention-des-bronchiolites-a-virus-respiratoire-syncytial-vrs-chez-les-nouveau-nes-et-les-nourrissons.
   Google Scholar
• Francisco L, Cruz-Cañete M, Pérez C, Couceiro JA, Otheo E, Launes C, Rodrigo C, Jiménez AB, Llorente M, Montesdeoca A, et al. Nirsevimab for the prevention of respiratory syncytial virus disease in children. Anales de Pediatría (English Edition). 2023;99(4):257–63. doi: 10.1016/j.anpede.2023.09.006.
   Google Scholar
• CDC, University of Iowa. RAND survey unpublished data. Slide 95, evidence to recommendations framework: Nirsevimab. ACIP general meeting; 2023 Feb 23 [accessed 2023 Oct 26]. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-02/slides-02-23/rsv-pediatric-04-jones-508.pdf.
   Google Scholar
• Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, et al. Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta-analysis. J Infect Dis. 2020;222(Supplement_7):680–87. doi: 10.1093/infdis/jiz683.
   PubMedGoogle Scholar